Strategies and End Points in the Development of Novel Immunotherapy Trials for Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer Association of Chronic Hepatitis B Infection and ...
Overall, TherVacB was found to be safe, well-tolerated, and highly immunogenic among the healthy study participants.
CHB Fall 2024 ready-to-wear runway, fashion show & collection photos. Designed by CHB at Milan Fashion Week, February 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results